Results 51 to 60 of about 1,819,303 (176)
Chronic respiratory disease burden in the 2023‐defined WHO Western Pacific Region, 1990–2023: Using the Global Burden of Disease 2023 estimates, this study characterized the incidence, prevalence, deaths, and disability‐adjusted life years (DALYs) associated with chronic respiratory diseases (CRDs) in the 37 WHO Western Pacific Region Member States and
Zhang Yue +7 more
wiley +1 more source
Online home spirometry in national pulmonary fibrosis care: insights from daily practice
Background Monitoring lung function course in patients with pulmonary fibrosis is crucial to guide treatment decisions. Online home spirometry holds great potential for close monitoring and improving care access in times of pressured healthcare systems ...
Gizal Nakshbandi +14 more
doaj +1 more source
Predicting total lung capacity from spirometry: a machine learning approach
Background and objectiveSpirometry patterns can suggest that a patient has a restrictive ventilatory impairment; however, lung volume measurements such as total lung capacity (TLC) are required to confirm the diagnosis.
Luka Beverin +6 more
doaj +1 more source
Electronic feedback messages for home spirometry lung transplant recipients [PDF]
Lung transplant recipients use a telemedicine device known as the electronic home spirometer to gauge the function of their lungs when they are away from the hospital or clinic setting. Health care providers review transmitted spirometry tests and user's symptom responses to detect early signs of infection and or rejection.
Sarah J, Pangarakis +4 more
openaire +2 more sources
ABSTRACT Introduction/Aims Phrenic nerve involvement in neuralgic amyotrophy (NA) may cause diaphragm paresis and respiratory impairment, for which chronic non‐invasive ventilation (NIV) may be beneficial. Data on treatment success and predictors are lacking.
A. B. Hendrikx +6 more
wiley +1 more source
Background The extend of lung disease remains the most important prognostic factor for survival in patients with cystic fibrosis (CF), and lack of adherence is the main reason for treatment failure.
Stephanie Thee +11 more
doaj +1 more source
Clinical Outcomes and Acute Exacerbation Incidence in Combined Pulmonary Fibrosis and Emphysema
This multicentre prospective study of 1016 patients demonstrated that CPFE, defined as ≥ 5% emphysema on visual CT assessment, identified a high‐risk phenotype with significantly worse 5‐year survival compared to non‐CPFE IIP patients (51.4% vs. 63.1%) and COPD patients (51.4% vs. 84.0%) and higher acute exacerbation incidence, validating international
Kazuya Tsubouchi +23 more
wiley +1 more source
Safety and tolerability of pirfenidone in asbestosis: a prospective multicenter study
Background Pirfenidone slows down disease progression in idiopathic pulmonary fibrosis (IPF). Recent studies suggest a treatment effect in progressive pulmonary fibrosis other than IPF.
Jelle R. Miedema +7 more
doaj +1 more source
ABSTRACT Sargassum inundation of Caribbean and American shorelines is a growing environmental hazard. Hydrogen sulfide (H2S) and ammonia (NH3) produced by decomposing Sargassum could be involved in airway obstruction and bronchial inflammation. The study was undertaken to evaluate the effects of exposure to H2S and NH3 gases emitted during Sargassum ...
Rishika Banydeen +9 more
wiley +1 more source
Monitoring respiratory function with telemedicine devices in asthmatic children
IntroductionPediatric asthma requires continuous monitoring, traditionally reliant on in-person assessments. Home-based telespirometry offers a promising approach, enabling regular lung function testing, early exacerbation detection, and improved disease
Katalin Kapus +5 more
doaj +1 more source

